Literature DB >> 8598462

Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor.

C L Tucek-Szabo1, S Andjelić, E Lacy, K B Elkon, J Nikolić-Zugić.   

Abstract

Fas-mediated apoptosis is a form of cell death that operates through a receptor-ligand interaction. The FasR has been implicated directly in peripheral T cell tolerance and activation-induced apoptosis of T cells in vitro, although to date its expression on murine peripheral T cells has been characterized incompletely. In this study, we document substantial expression of FasR on the vast majority of recent thymic emigrants and resting peripheral T lymphocytes. FasR ligation can induce death in a minor (approximately 5%) subset of these cells. By contrast to rather slow activation-mediated FasR up-regulation in vitro, we demonstrate that in vivo T cell activation by alpha CD3 mAb or superantigen results in rapid up-regulation of the FasR. This up-regulation is paralleled by the kinetics of activation-induced apoptosis in lymph node T cells. However, we demonstrate that the FasR is not necessary for activation-induced cell death. Lymph node T cells from young, healthy, FasR expression-deficient MRL-Ipr/Ipr and animals could be activated in vivo through the TCR-CD3 complex. Most importantly, MRL-Ipr/Ipr T cells underwent massive activation-induced apoptosis in response to high and intermediate doses of alpha CD3. At a low alpha CD3 dose, however, both MRL-Ipr/Ipr and MRL +/+ T cells were activated similarly, but only the latter underwent adequate apoptosis. Taken together, these findings suggest that in vivo, the Fas pathway may not be the only regulator of activation-induced T cell death, but that this pathway may be critical in regulating responses to weak stimuli.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598462

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  T cell apoptosis and reactive oxygen species.

Authors:  David A Hildeman; Thomas Mitchell; John Kappler; Philippa Marrack
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

2.  Programmed cell death (apoptosis) in cord blood lymphocytes.

Authors:  S Aggarwal; A Gupta; S Nagata; S Gupta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

3.  Anti-alpha 4 integrin antibody induces apoptosis in murine thymocytes and staphylococcal enterotoxin B-activated lymph node T cells.

Authors:  E Z Tchilian; J J Owen; E J Jenkinson
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

4.  Apoptosis in a Fas-resistant, T-cell receptor-sensitive human leukaemic T-cell clone.

Authors:  L L Delehanty; J A Payne; S N Farrow; R Brown; B R Champion
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

Review 5.  The future of interleukin-2: enhancing therapeutic anticancer vaccines.

Authors:  W W Overwijk; M R Theoret; N P Restifo
Journal:  Cancer J Sci Am       Date:  2000-02

6.  T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis.

Authors:  T Jayaraman; A R Marks
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

7.  Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death.

Authors:  Min Li-Weber; Markus A Weigand; Marco Giaisi; Dorothee Süss; Monika K Treiber; Sven Baumann; Elena Ritsou; Raoul Breitkreutz; Peter H Krammer
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.

Authors:  E A Elliott; H I McFarland; S H Nye; R Cofiell; T M Wilson; J A Wilkins; S P Squinto; L A Matis; J P Mueller
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

9.  CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens.

Authors:  Xue-Zhong Yu; Michael H Albert; Paul J Martin; Claudio Anasetti
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

10.  CD4+ CCR5+ and CD4+ CCR3+ lymphocyte subset and monocyte apoptosis in patients with acute visceral leishmaniasis.

Authors:  Marcella Potestio; Pietro D'Agostino; Giuseppina Colonna Romano; Salvatore Milano; Viviana Ferlazzo; Alessandra Aquino; Gloria Di Bella; Rosalba Caruso; Giuseppe Gambino; Giustina Vitale; Serafino Mansueto; Enrico Cillari
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.